DNA vaccine expressing repeated carcinoembryonic antigen (CEA) 625-667 induces strong immunity in mice

Immunology Letters

Volumn 135, Issue 1-2, 2011, Pages 124-128

  Li, Dan ^a   Hua, Shucheng ^a   Fan, Yanqiu ^a   Xu, Shufen ^a   Duan, Xiumei ^a   Liu, Lihua ^a   Che, Yuanyuan ^a   Li, Shulei ^a   Tan, Yan ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Carcinoembryonic antigen; DNA plasmid; Epitope

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DNA FRAGMENT; DNA VACCINE; GAMMA INTERFERON; PLASMID DNA; THYMIDINE; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TH1 CELL; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIBODY FORMATION; CARCINOEMBRYONIC ANTIGEN; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; EPITOPES, T-LYMPHOCYTE; FEMALE; MICE; MICE, INBRED BALB C; NEOPLASMS; PEPTIDES; TH1 CELLS; VACCINATION; VACCINES, DNA;

EID: 78751704630     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.10.012     Document Type: Article

References (16)

1. Dupuy L.C., Schmaljohn C.S. DNA vaccines for biodefense. Expert Rev Vaccines 2009, 8:1739-1754.
2. Frenoy N., Schauffler J., Cahour A., Burtin P. Natural antibodies against the carcinoembryonic antigen (CEA) and a related antigen, NCA, in human sera. Anticancer Res 1987, 7:1229-1233.
3. Gold P., Freedman S.O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965, 121:439-462.
4. Greiner J.W., Zeytin H., Anver M.R., Schlom J. Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity. Cancer Res 2002, 62:6944-6951.
5. Hou Y., Kavanagh B., Fong L. Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen. J Immunol 2008, 180:1526-1534.
6. Jothy S., Brazinsky S.A., Chin A.L.M., Haggarty A., Krantz M.J., Cheung M., et al. Characterization of monoclonal antibodies to carcinoembryonic antigen with increased tumor specificity. Lab Invest 1986, 54:108-117.
7. Kranzer K., Bauer M., Lipford G.B., Heeg K., Wagner H., Lang R. CpG-oligodeoxynucleotides enhance T-cell receptor-triggered interferon-gamma production and up-regulation of CD69 via induction of antigen-presenting cell-derived interferon type I and interleukin-12. Immunology 2000, 99:170-178.
8. Li D., Fang Y.Q., Tan Y., Liu L.H. Study of specific proliferation of lymphocytes from mice induced by carcinoembryonic antigen minigene peptide which expressed in Escherichia coli. Immunol J (China) 2008, 24:400-403. [In Chinese].
9. Liu B., Li G., Sui X., Yin J., Wang H., Ren X. Expression and functional analysis of porcine aminopeptidase N produced in prokaryotic expression system. J Biotechnol 2009, 141:91-96.
10. Oikawa S., Nakazato H., Kosaki G. Primary structure of human carcinoembryonic antigen (CEA) deduced from cDNA sequence. Biochem Biophys Res Commun 1987, 142:511-518.
11. Rice J., Elliott T., Buchan S., Stevenson F.K. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines. J Immunol 2001, 167:1558-1565.
12. Salajegheh M, Kong SW, Pinkus JL, Walsh RJ, Liao A, Nazareno R, et al. Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol 67:53-63.
13. Ura Y., Ochi Y., Hamazu M., Ishida M., Nakajima K., Watanabe T. Studies on circulating antibody against carcinoembryonic antigen (CEA) and CEA-like antigen in cancer patients. Cancer Lett 1985, 25:283-295.
14. Wang P., Xu T.Y., Guan Y.F., Su D.F., Fan G.R., Miao C.Y. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 2009, 81:370-380.
15. Yamamoto S., Yamamoto T., Shimada S., Kuramoto E., Yano O., Kataoka T., et al. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 1992, 36:983-997.
16. You Z., Huang X., Hester J., Toh H.C., Chen S.Y. Targeting dendritic cells to enhance DNA vaccine potency. Cancer Res 2001, 61:3704-3711.